Who owns ACURX PHARMACEUTICALS INC COM NEW?
- Ticker: ACXP
- CUSIP Number: 00510m203
Tip: Access positions for across all investors
Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acurx Pharmaceuticals stock
Who bought or sold ACURX PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 55k | $203k | 409% | Mar 2026 |
|
| Vanguard Capital Management | 31k | $115k | 100% | Mar 2026 |
|
| Geode Capital Management | 25k | $92k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 20k | $74k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 16k | $60k | 100% | Mar 2026 |
|
| Prospect Financial Services | 14k | $51k | -30% | Mar 2026 |
|
| Morgan Stanley | 6.5k | $24k | 0% | Mar 2026 |
|
| UBS Group | 6.3k | $24k | 3635% | Mar 2026 |
|
| Wells Fargo & Company | 2.3k | $8.5k | 0% | Mar 2026 |
|
| Westside Investment Management | 1.7k | $6.1k | 100% | Mar 2026 |
|
| Nbc Securities | 1.5k | $5.6k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.0k | $3.8k | -64% | Mar 2026 |
|
| Mcguire Capital Advisors | 1.0k | $3.7k | 100% | Mar 2026 |
|
| Barclays | 380.00 | $1.4k | 100% | Mar 2026 |
|
| Group One Trading | 245.00 | $908.999000 | -13% | Mar 2026 |
|
| Cornerstone Planning Group | 167.00 | $334.000000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 100.00 | $371.000000 | 0% | Mar 2026 |
|
| BlackRock | 60.00 | $223.002000 | 0% | Mar 2026 |
|
| Advisory Services Network | 59.00 | $219.002100 | 100% | Mar 2026 |
|
| SBI Securities | 6.00 | $22.000200 | -54% | Mar 2026 |
|
| Citigroup | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Acurx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2025 | 41k | $103k |
| Northern Trust | Dec 2025 | 17k | $42k |